Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Capodanno

Showing results (201-210 of 778) with videos related to

Pageof 78
Sort By:
European Heart Journal|December 2, 2009
Platelet thrombin receptor antagonism and atherothrombosisDominick J Angiolillo, Davide Capodanno, Shinya Goto
Interventional Cardiology Clinics|September 8, 2024
Antithrombotic Therapy in Patients with Chronic Coronary SyndromesPlacido Maria Mazzone, Marco Spagnolo, Davide Capodanno
Journal of Clinical Medicine|April 27, 2024
Current Management of In-Stent RestenosisDaniele Giacoppo, Placido Maria Mazzone, Davide Capodanno
European Heart Journal. Acute Cardiovascular Care|June 28, 2021
Diagnostic pathways in myocardial infarction with non-obstructive coronary artery disease (MINOCA)Giovanni Occhipinti, Chiara Bucciarelli-Ducci, Davide Capodanno
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 2, 2010
Impact of right coronary artery disease on mortality in patients undergoing percutaneous coronary intervention of unprotected left main coronary artery diseaseDavide Capodanno, Maria-Elena Di Salvo, Corrado Tamburino
Expert Review of Cardiovascular Therapy|November 26, 2015
Antithrombotic therapy following transcatheter aortic valve implantation: what challenge do we face?Marco Barbanti, Simona Gulino, Corrado Tamburino, et al.
Therapeutic Advances in Cardiovascular Disease|December 12, 2019
Intravenous antiplatelet therapies (glycoprotein IIb/IIIa receptor inhibitors and cangrelor) in percutaneous coronary intervention: from pharmacology to indications for clinical useDavide Capodanno, Rocco P Milluzzo, Dominick J Angiolillo
Future Cardiology|February 3, 2021
Canakinumab for secondary prevention of coronary artery diseaseLuis Ortega-Paz, Davide Capodanno, Dominick J Angiolillo
Journal of Clinical Medicine|November 27, 2025
Intravascular Imaging Guidance for Percutaneous Coronary InterventionsMarco Spagnolo, Daniele Giacoppo, Antonio Greco, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|May 8, 2015
Current status and clinical development of transcatheter approaches for severe mitral regurgitationCarmelo Grasso, Davide Capodanno, Corrado Tamburino, et al.
Pageof 78

Showing results (201-210 of 778) with videos related to

Sort By:
Pageof 78
European Heart Journal|December 2, 2009
Platelet thrombin receptor antagonism and atherothrombosisDominick J Angiolillo, Davide Capodanno, Shinya Goto
Interventional Cardiology Clinics|September 8, 2024
Antithrombotic Therapy in Patients with Chronic Coronary SyndromesPlacido Maria Mazzone, Marco Spagnolo, Davide Capodanno
Journal of Clinical Medicine|April 27, 2024
Current Management of In-Stent RestenosisDaniele Giacoppo, Placido Maria Mazzone, Davide Capodanno
European Heart Journal. Acute Cardiovascular Care|June 28, 2021
Diagnostic pathways in myocardial infarction with non-obstructive coronary artery disease (MINOCA)Giovanni Occhipinti, Chiara Bucciarelli-Ducci, Davide Capodanno
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 2, 2010
Impact of right coronary artery disease on mortality in patients undergoing percutaneous coronary intervention of unprotected left main coronary artery diseaseDavide Capodanno, Maria-Elena Di Salvo, Corrado Tamburino
Expert Review of Cardiovascular Therapy|November 26, 2015
Antithrombotic therapy following transcatheter aortic valve implantation: what challenge do we face?Marco Barbanti, Simona Gulino, Corrado Tamburino, et al.
Therapeutic Advances in Cardiovascular Disease|December 12, 2019
Intravenous antiplatelet therapies (glycoprotein IIb/IIIa receptor inhibitors and cangrelor) in percutaneous coronary intervention: from pharmacology to indications for clinical useDavide Capodanno, Rocco P Milluzzo, Dominick J Angiolillo
Future Cardiology|February 3, 2021
Canakinumab for secondary prevention of coronary artery diseaseLuis Ortega-Paz, Davide Capodanno, Dominick J Angiolillo
Journal of Clinical Medicine|November 27, 2025
Intravascular Imaging Guidance for Percutaneous Coronary InterventionsMarco Spagnolo, Daniele Giacoppo, Antonio Greco, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|May 8, 2015
Current status and clinical development of transcatheter approaches for severe mitral regurgitationCarmelo Grasso, Davide Capodanno, Corrado Tamburino, et al.
Pageof 78